Albert Dahan Selected Research

Hyperalgesia

1/2021	Efficacy of ketamine in relieving neuropathic pain: a systematic review and meta-analysis of animal studies.
1/2020	Hyperalgesia and Reduced Offset Analgesia During Spinal Anesthesia.
12/2019	Pharmacokinetic and pharmacodynamic considerations for NMDA-receptor antagonist ketamine in the treatment of chronic neuropathic pain: an update of the most recent literature.
7/2016	Targeting the innate repair receptor to treat neuropathy.
1/2016	Is Intraoperative Remifentanil Associated With Acute or Chronic Postoperative Pain After Prolonged Surgery? An Update of the Literature.
2/2014	ARA 290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain coupled with suppression of the spinal microglia response.
1/2013	Ketamine does not produce relief of neuropathic pain in mice lacking the β-common receptor (CD131).
12/2012	Morphine induces hyperalgesia without involvement of μ-opioid receptor or morphine-3-glucuronide.
11/2012	Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot study.
8/2012	Estimation of the contribution of norketamine to ketamine-induced acute pain relief and neurocognitive impairment in healthy volunteers.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Albert Dahan Research Topics

Disease

83	Pain (Aches) 01/2023 - 01/2004
65	Respiratory Insufficiency (Respiratory Failure) 01/2024 - 02/2003
34	Chronic Pain 03/2023 - 10/2009
23	Postoperative Pain 03/2024 - 06/2006
19	Neuralgia (Stump Neuralgia) 01/2021 - 07/2008
17	Hyperalgesia 01/2021 - 06/2009
10	Hypoxia (Hypoxemia) 01/2024 - 11/2002
9	Opiate Overdose 02/2024 - 03/2007
8	Apnea 07/2023 - 06/2010
8	Acute Pain 01/2018 - 11/2004
8	Complex Regional Pain Syndromes 04/2015 - 10/2009
7	Fibromyalgia (Fibrositis) 01/2023 - 10/2011
6	Opioid-Related Disorders (Opiate Addiction) 01/2024 - 03/2007
6	Cancer Pain 01/2017 - 01/2006
5	Sarcoidosis (Schaumann Disease) 01/2018 - 01/2012
5	Nausea 01/2018 - 06/2006
5	Vomiting 02/2014 - 06/2006
4	Neoplasms (Cancer) 03/2013 - 07/2008
3	Body Weight (Weight, Body) 01/2024 - 02/2015
3	Hypercapnia 01/2023 - 05/2006
3	Heart Arrest (Cardiac Arrest) 01/2023 - 01/2016
3	Miosis 01/2023 - 05/2015
3	Hyperoxia 12/2021 - 04/2004
3	Chronic Pancreatitis 11/2019 - 12/2012
3	Sleep Apnea Syndromes (Sleep Apnea) 10/2019 - 04/2004
3	Postoperative Nausea and Vomiting (PONV) 04/2011 - 05/2008
2	Brain Hypoxia (Cerebral Hypoxia) 01/2024 - 01/2024
2	Pulmonary Edema 01/2024 - 03/2007
2	Drug Overdose 07/2023 - 10/2021
2	Headache (Headaches) 03/2023 - 01/2023
2	Osteoarthritis 01/2023 - 01/2022
2	Renal Insufficiency (Renal Failure) 01/2022 - 11/2015
2	Obesity 12/2017 - 07/2014
2	Pneumoperitoneum 11/2017 - 08/2015
2	Peripheral Nerve Injuries 07/2016 - 11/2011
2	Type 2 Diabetes Mellitus (MODY) 07/2016 - 03/2015
2	Hallucinations (Hallucination) 12/2015 - 02/2014

Drug/Important Bio-Agent (IBA)

86	Opioid Analgesics (Opioids)IBA 01/2024 - 03/2005
39	Analgesics (Analgesic Drugs)IBA 03/2023 - 02/2003
33	Ketamine FDA LinkGeneric 03/2023 - 10/2009
29	Morphine (MS Contin)FDA LinkGeneric 01/2023 - 10/2003
23	Fentanyl (Sublimaze)FDA LinkGeneric 01/2024 - 01/2006
20	Naloxone (Narcan)FDA LinkGeneric 02/2024 - 02/2003
15	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2019 - 06/2009
13	Buprenorphine (Subutex)FDA LinkGeneric 01/2022 - 01/2006
12	EsketamineIBA 01/2017 - 10/2009
11	Remifentanil (Ultiva)FDA Link 10/2022 - 06/2010
10	Opioid Receptors (Opioid Receptor)IBA 01/2022 - 02/2003
10	morphine-6-glucuronideIBA 12/2017 - 10/2003
8	Carbon DioxideIBA 01/2023 - 04/2004
7	Biomarkers (Surrogate Marker)IBA 04/2023 - 01/2008
7	Narcotic Antagonists (Opioid Antagonists)IBA 11/2022 - 07/2006
6	Oxycodone (Oxycontin)FDA LinkGeneric 01/2023 - 07/2008
6	mu Opioid Receptors (mu Opioid Receptor)IBA 11/2022 - 03/2005
6	cibinetideIBA 01/2018 - 11/2011
5	Alfentanil (Alfenta)FDA LinkGeneric 10/2022 - 07/2005
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 11/2011
4	N-Methylaspartate (NMDA)IBA 03/2023 - 01/2010
4	Naltrexone (ReVia)FDA LinkGeneric 01/2022 - 06/2009
4	Sufentanil (Sufenta)FDA LinkGeneric 01/2022 - 11/2007
4	norketamineIBA 01/2022 - 10/2009
4	Erythropoietin FDA Link 03/2015 - 11/2011
4	Peptides (Polypeptides)IBA 03/2015 - 11/2011
3	Isoflurane FDA LinkGeneric 01/2023 - 04/2005
3	Methadone (Dolophine)FDA LinkGeneric 01/2022 - 07/2008
3	Propofol (Diprivan)FDA LinkGeneric 10/2021 - 04/2002
3	Tapentadol FDA Link 11/2020 - 01/2015
3	Pregabalin (Lyrica)FDA Link 11/2019 - 12/2012
3	Dizocilpine Maleate (Dizocilpine)IBA 01/2010 - 06/2009
3	Acetazolamide (Diamox)FDA LinkGeneric 01/2010 - 04/2004
2	Oxygen (Dioxygen)IBA 01/2024 - 04/2004
2	Respiratory System Agents (Respiratory Stimulants)IBA 07/2023 - 01/2018
2	Hydromorphone (Dilaudid)FDA LinkGeneric 01/2023 - 07/2008
2	((3- methoxythiophen- 2- yl)methyl)((2- (9- (pyridin- 2- yl)- 6- oxaspiro(4.5)decan- 9- yl)ethyl))amineIBA 01/2023 - 01/2020
2	Dronabinol (THC)FDA LinkGeneric 01/2023 - 04/2019
2	BenzodiazepinesIBA 10/2022 - 01/2022
2	Antidepressive Agents (Antidepressants)IBA 10/2022 - 01/2017
2	Thyrotropin-Releasing Hormone (Protirelin)FDA Link 01/2022 - 01/2022
2	Hypnotics and Sedatives (Sedatives)IBA 01/2022 - 01/2016
2	Neostigmine (Neostigmine Bromide)IBA 01/2022 - 01/2019
2	SugammadexIBA 01/2022 - 01/2019
2	Retinaldehyde (Retinal)IBA 12/2021 - 01/2021
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2019 - 01/2018
2	TabletsIBA 01/2018 - 01/2018
2	morphine-3-glucuronideIBA 12/2017 - 12/2012
2	insulin receptor-related receptor (IRR)IBA 07/2016 - 01/2013

Therapy/Procedure

40	Analgesia 01/2023 - 11/2004
13	Therapeutics 01/2022 - 01/2007
5	Epidural Analgesia 01/2018 - 11/2007
4	Pain Management 01/2023 - 09/2013
4	Bariatric Surgery 01/2023 - 01/2016
4	Anesthesia 01/2022 - 01/2019
4	Nephrectomy 01/2020 - 08/2015
3	Spinal Anesthesia 01/2022 - 08/2014
3	Patient-Controlled Analgesia (Analgesia, Patient Controlled) 01/2018 - 07/2012
3	Aftercare (After-Treatment) 01/2015 - 07/2011
2	Injections 01/2024 - 01/2022
2	Arthroplasty 01/2023 - 01/2022
2	Drug Therapy (Chemotherapy) 01/2022 - 04/2015
2	Length of Stay 10/2020 - 07/2019